Persistent URL of this record https://hdl.handle.net/1887/121015
Documents
-
- Download
- Clinical_pharmacology_&_therapeutics_10.1002
- Not Applicable (or Unknown)
- open access
In Collections
This item can be found in the following collections:
Vedolizumab for Inflammatory Bowel Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study ICC Registry - Vedolizumab
- All authors
- Biemans, V.B.C.; Woude, C.J. van der; Dijkstra, G.; Meulen-de Jong, A.E. van der; Oldenburg, B.; Boer, N.K. de; Lowenberg, M.; Srivastava, N.; Bodelier, A.G.L.; West, R.L.; Jansen, J.M.; Vries, A.C. de; Haans, J.J.L.; Jong, D.J. de; Pierik, M.J.; Hoentjen, F.; Dutch Initiative Crohn Colitis
- Date
- 2019-12-11